As these metabolic disorders are important risk factors of CKD, the improvements in systemic glucose and lipid metabolism by SIRT1 may also contribute to the attenuated kidney disorders due to maternal HFD in the offspring. This evidence concerns the gene SIRT1 and metabolic disease.